CDKN1B anticorps (C-Term)
Aperçu rapide pour CDKN1B anticorps (C-Term) (ABIN646838)
Antigène
Voir toutes CDKN1B AnticorpsReactivité
Hôte
Conjugué
Application
-
-
Épitope
- C-Term
-
Réactivité croisée
- Humain, Souris, Rat (Rattus), Boeuf (Vache), Chien
-
Attributs du produit
- Goat Anti-P27KIP1 / CDKN1B (C Terminus)
-
Immunogène
- Peptide with sequence C-EQTPKKPGLRRRQT, from the C Terminus of the protein sequence according to NP_004055.1.
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
-
- CDKN1B (Cyclin-Dependent Kinase Inhibitor 1B (p27, Kip1) (CDKN1B))
-
Autre désignation
- P27KIP1 / CDKN1B
-
Sujet
- Synonyms: CDKN1B, cyclin-dependent kinase inhibitor 1B (p27, Kip1), KIP1, CDKN4, P27KIP1, cyclin-dependent kinase inhibitor 1B, p27(KIP1), KIP1, p27
-
NCBI Accession
- NP_004055
-
Pathways
- Cycle Cellulaire, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Positive Regulation of Peptide Hormone Secretion, Negative Regulation of Hormone Secretion, Sensory Perception of Sound, Mitotic G1-G1/S Phases, DNA Replication, Positive Regulation of Endopeptidase Activity, Synthesis of DNA, Autophagy
Antigène
-